The final in a series on the need to formally prioritise patient input in HTA decision-making, we argue that the system currently lacks the ethical framework necessary to make morally defensible decisions. No system of decision-making can be considered ethical when its rules, when properly applied, lead to outcomes that delay access to treatment with consequent suffering, harm, and in some cases, death.
If the system properly applied results in harm, then the problem is worse than we think
November 20, 2025 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
An institution dominated by very clever people, but where is the wisdom?
August 14, 2026 - - Latest News -
A plain language version of these dreadful and useless documents
August 14, 2026 - - Latest News -
CUREator+ backs six Australian startups with $13.5 million to advance new health technologies
August 13, 2026 - - Australian Biotech -
Medicines Australia appoints former AbbVie executive to key leadership role
August 13, 2026 - - Latest News -
VVMF and Optosleep partner to advance Australian gene therapy for sleep apnoea
August 13, 2026 - - Latest News -
Survey exposes deep gaps in neurological care across Australia
August 13, 2026 - - Latest News -
Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product
August 13, 2026 - - Latest News

